Ripple kopen? Dit zijn de mogelijkheden

Oasmia Pharmaceutical Aandeel

6,34SEK -0,70SEK -9,95%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Oasmia Pharmaceutical AB - Profiel

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Aandeelhouder

Eigenaar in %
Freefloat64,39
Per Axel Arwidsson18,33
Avanza Bank Holding AB8,81
Alceco International S.A.4,67
Nordnet AB3,36
AM Karlsson I Kvicksund AB1,41
SEB Investment Management AB0,53
Xact Kapitalförvaltning AB0,44
Andra AP-fonden0,26
Skandia Investment Management AB0,05
Storebrand Asset Management AS0,04
Danske Bank A/S (Investment Management Sweden)0,03
Catella Fondförvaltning AB0,02
Swedbank AB0,00

Adres

Vallongatan 1, 752 28 Uppsala
Postbus:
Telefoon: 4618505440
Fax: 4618510873
Internet: http://www.oasmia.com

Management

Lars Jörgen Olsson
Chairman
Sven Rohmann MD, PhD
Chief Executive Officer & Director
Joakim Lindén
Chief Financial Officer
Nina Heldring, PhD
Chief Medical Officer
Mikael Asp
Chief Technology Officer
Anette Sjödin
Executive Vice President
Magdalena Berg
Head-Accounting
Maria Nilsson Hagberg
Head-Regulatory Affairs
Isak Peter Zonabend
Independent Director
Gunilla Ohman, MBA
Independent Director

Invoer toevoegen